Dow Jones

38 860,43

-0,07%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Regen Biopharma Inc (PK) (RGBPP)
Regen Biopharma Inc (PK) (RGBPP) Actualités

RGBPP

Regen Biopharma (PK) (RGBPP)

Regen Biopharma Inc (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:RGBPP

Date	Heure	Source	Titre	Symbole	Société
29/05/2024	19h12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
29/05/2024	19h11	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2024	19h29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
20/11/2023	15h37	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:RGBPP	Regen Biopharma Inc (PK)
02/10/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:RGBPP	Regen Biopharma Inc (PK)
25/09/2023	17h25	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:RGBPP	Regen Biopharma Inc (PK)
24/07/2023	20h59	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/05/2023	16h27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/05/2023	12h28	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:RGBPP	Regen Biopharma Inc (PK)
13/04/2023	12h29	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGBPP	Regen Biopharma Inc (PK)
21/03/2023	18h52	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
19/01/2023	21h42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)
15/11/2022	21h38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
22/12/2021	20h46	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:RGBPP	Regen Biopharma Inc (PK)
31/08/2021	21h50	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:RGBPP	Regen Biopharma Inc (PK)
09/04/2021	15h08	InvestorsHub NewsWire	PAOG Signals BULLISH - Two CBD Therapeutics In Play	USOTC:RGBPP	Regen Biopharma Inc (PK)
03/03/2020	16h54	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:RGBPP	Regen Biopharma Inc (PK)
24/05/2019	19h01	Edgar (US Regulatory)	Amended Notification That Quarterly Report Will Be Submitted Late (nt 10-q/a)	USOTC:RGBPP	Regen Biopharma Inc (PK)
14/05/2019	12h02	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)
28/12/2017	17h26	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
28/04/2017	22h41	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:RGBPP	Regen Biopharma Inc (PK)